<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7136267/results/search/disease/results.xml">
  <result pre="carotenoid bacterioruberin was found to be the predominant compound. Because" exact="cancer" post="and viral hepatitis are serious diseases, the anticancer, anti-HCV"/>
  <result pre="was found to be the predominant compound. Because cancer and" exact="viral hepatitis" post="are serious diseases, the anticancer, anti-HCV and anti-HBV potentials"/>
  <result pre="found to be the predominant compound. Because cancer and viral" exact="hepatitis" post="are serious diseases, the anticancer, anti-HCV and anti-HBV potentials"/>
  <result pre="suppresses HCV and HBV replication, as indicated by a high" exact="viral" post="clearance % in the treated cells. These novel findings"/>
  <result pre="and utilizes a wide range of carbohydrate and noncarbohydrate substrates." exact="Carotenoids" post="are lipid-soluble pigments that vary in colour between yellow,"/>
  <result pre="pigments that vary in colour between yellow, orange, and red." exact="Carotenoids" post="are classified based on the number of carbons in"/>
  <result pre="for new sources of such important bioactive compounds. Hence, after" exact="partial" post="extraction of carotenoids produced by the haloalkaliphilic archaeon Natrialba"/>
  <result pre="apoptosis-dependent cell death and for blocking matrix metalloprotease (MMP) 9-dependent" exact="cancer" post="progression (angiogenesis and metastasis)12. Additionally, we investigated the antiviral"/>
  <result pre="antiviral activity of these carotenoids by assessing their impact on" exact="hepatitis" post="C virus (HCV) RNA-dependent RNA and hepatitis B virus"/>
  <result pre="their impact on hepatitis C virus (HCV) RNA-dependent RNA and" exact="hepatitis" post="B virus (HBV) DNA-dependent DNA polymerase-mediated viral replication. This"/>
  <result pre="RNA-dependent RNA and hepatitis B virus (HBV) DNA-dependent DNA polymerase-mediated" exact="viral" post="replication. This evaluation will open the door for more"/>
  <result pre="was safe without generating any hemolysis while 4.699 ± 0.0706 mg/ml of it" exact="ruptured" post="RBCs by 50%. In vitro anticancer efficacy of the"/>
  <result pre="of the Natrialba sp. M6 pigment on human normal and" exact="cancer" post="cell lines The cytotoxic effect of the studied pigment"/>
  <result pre="cells. However, 5-FU caused 50% cell death for Caco-2 (colon" exact="cancer" post="line), MCF-7 (breast cancer cell line), HepG-2 (liver cancer"/>
  <result pre="50% cell death for Caco-2 (colon cancer line), MCF-7 (breast" exact="cancer" post="cell line), HepG-2 (liver cancer line), and HeLa (cervical"/>
  <result pre="(colon cancer line), MCF-7 (breast cancer cell line), HepG-2 (liver" exact="cancer" post="line), and HeLa (cervical cancer cell line) cells at"/>
  <result pre="cancer cell line), HepG-2 (liver cancer line), and HeLa (cervical" exact="cancer" post="cell line) cells at a dose (7.17–10.36 µg/ml) less than"/>
  <result pre="pigment (Fig. 4B). The IC50 values of 5-FU against human" exact="cancer" post="cells were higher than its safe dose (EC100), clarifying"/>
  <result pre="On the other hand, IC50 values of pigment for human" exact="cancer" post="cell lines did not obviously exceed its EC100 limit."/>
  <result pre="pigment having a higher selectivity index (SI &amp;gt; 2) between normal and" exact="cancer" post="cells than 5-FU does (SI &amp;lt; 1.7) (Fig. 4C). Furthermore, Fig."/>
  <result pre="the morphological changes (loss of spindle shapes) in pigment-treated human" exact="cancer" post="cell lines (Caco-2, MCF-7, HepG-2 and HeLa) without any"/>
  <result pre="In contrast, cell damage was observed in both normal and" exact="cancer" post="cells treated with 5-FU, as shown in Fig. 4D."/>
  <result pre="Cytotoxicity effect of the extracted pigments on human normal and" exact="cancer" post="cells. (A) EC50 and EC100 (µg/ml) of pigment extract"/>
  <result pre="(Wi-38) and (B) their IC50 (µg/ml) values against four human" exact="cancer" post="cell lines. (C) Selectivity index (SI) of pigments against"/>
  <result pre="cancer cell lines. (C) Selectivity index (SI) of pigments against" exact="cancer" post="cells compared with that of 5-FU. (D) Variation in"/>
  <result pre="cells compared with that of 5-FU. (D) Variation in the" exact="morphology" post="of normal and cancer cells after treatment with the"/>
  <result pre="of 5-FU. (D) Variation in the morphology of normal and" exact="cancer" post="cells after treatment with the extracted pigments and 5-FU"/>
  <result pre="cytometric analysis of the annexin-stained apoptotic cell population in pigment-treated" exact="cancer" post="cells, which was 48.87–53.55%, contrasting the less than 39%"/>
  <result pre="more potent as an inducer of apoptosis in all tested" exact="cancer" post="cells (Caco-2, MCF-7, HepG-2 and HeLa) than the reference"/>
  <result pre="late apoptotic cells, respectively. As shown in Fig. 5C, pigment-treated" exact="cancer" post="cells mainly exhibited yellow, orange and red fluorescence, while"/>
  <result pre="cells mainly exhibited yellow, orange and red fluorescence, while 5-FU-treated" exact="cancer" post="cells still demonstrated green fluorescence in four cancer cell"/>
  <result pre="while 5-FU-treated cancer cells still demonstrated green fluorescence in four" exact="cancer" post="cell lines. Moreover, the percentage of caspase 3/7 activation"/>
  <result pre="greater caspase-induced apoptotic effect than 5-FU on all studied human" exact="cancer" post="cell lines. Figure 5 Apoptotic effect of the extracted"/>
  <result pre="Figure 5 Apoptotic effect of the extracted pigments on human" exact="cancer" post="cells. (A) The apoptosis percentages in pigment- and 5-FU-treated"/>
  <result pre="cancer cells. (A) The apoptosis percentages in pigment- and 5-FU-treated" exact="cancer" post="cells after staining with annexin and propidium iodide relative"/>
  <result pre="annexin and propidium iodide relative to the percentages in untreated" exact="cancer" post="cells with (B) Dot plot flow charts of the"/>
  <result pre="(B) Dot plot flow charts of the untreated and treated" exact="cancer" post="cells. (C) Fluorescence images of pigment-treated cancer cells compared"/>
  <result pre="untreated and treated cancer cells. (C) Fluorescence images of pigment-treated" exact="cancer" post="cells compared with those of 5-FU-treated cancer cells and"/>
  <result pre="images of pigment-treated cancer cells compared with those of 5-FU-treated" exact="cancer" post="cells and untreated cancer cells after staining with acridine"/>
  <result pre="cells compared with those of 5-FU-treated cancer cells and untreated" exact="cancer" post="cells after staining with acridine orange and ethidium bromide"/>
  <result pre="on one of the key proteases (MMP-9) involved in several" exact="cancer" post="pathological processes, including invasion, angiogenesis and metastasis. As shown"/>
  <result pre="metastasis. As shown in Fig. 5E, our pigment had a" exact="lower" post="IC50 value than 5-FU for inhibiting MMP-9 (0.484 and"/>
  <result pre="estimated doses with HCV- and HBV-infected PBMCs, and then the" exact="viral" post="load was quantified by the fully automated Cobas Ampliprep"/>
  <result pre="Anti-HCV and anti-HBV activity of the extracted pigments. (A) The" exact="viral" post="clearance percentages in HCV- and HBV-infected peripheral blood mononuclear"/>
  <result pre="pigments. (A) The viral clearance percentages in HCV- and HBV-infected" exact="peripheral" post="blood mononuclear cells (PBMCs) after treatment with pigments or"/>
  <result pre="blood mononuclear cells (PBMCs) after treatment with pigments or standard" exact="viral" post="drugs (sofosbuvir and lamivudine for HCV and HBV, respectively)"/>
  <result pre="untreated infected PBMCs). (B) IC50 values of pigments and standard" exact="viral" post="drugs for inhibition of HCV-NS5B polymerase and DNA-dependent HBV"/>
  <result pre="&amp;lt;0.005**, &amp;lt;0.0005***. Inhibitory potential of the tested pigment against polymerase-dependent" exact="viral" post="replication Figure 6B shows that the pigment inhibited HCV"/>
  <result pre="(NS5B) than sofosbuvir did (p &amp;lt; 0.05). Meanwhile, this pigment revealed a" exact="lower" post="suppressor impact on HBV DNA-dependent DNA polymerase than lamivudine"/>
  <result pre="In addition, they have the advantage of inexpensive production and" exact="short" post="culture processing times. Due to the lack of studies"/>
  <result pre="was adjusted to 9–11. Pigments are usually produce as a" exact="secondary" post="metabolites, thus it is noteworthy that old cultures showed"/>
  <result pre="carotenoids with an effective impact on human diseases (cancer and" exact="viral" post="hepatitis). In our study, the concentration of Natrialba sp"/>
  <result pre="potent antiproliferative and apoptotic activity against colon, breast, liver and" exact="cervical cancer" post="cells. Previous study, in line with our findings, reported"/>
  <result pre="antiproliferative and apoptotic activity against colon, breast, liver and cervical" exact="cancer" post="cells. Previous study, in line with our findings, reported"/>
  <result pre="a higher anticancer effect, causing 50% death in all four" exact="cancer" post="cell lines at doses &amp;lt;39 µg/ml, compared to the above-mentioned"/>
  <result pre="V-stained apoptotic populations were &amp;gt;48% of the tested pigment-treated human" exact="cancer" post="cell lines (Caco-2, MCF-7, HepG-2, HeLa), whereas 5-FU-treated cancer"/>
  <result pre="human cancer cell lines (Caco-2, MCF-7, HepG-2, HeLa), whereas 5-FU-treated" exact="cancer" post="cells resulted in significantly smaller annexin V-stained apoptotic ppulations"/>
  <result pre="the caspase-dependent apoptotic impact of the extracted pigment for stimulating" exact="cancer" post="cell death was declared by their higher relative %"/>
  <result pre="prostate cells via upregulation of caspase 320,21. The prevention of" exact="cancer" post="progression is a promising therapeutic strategy against cancer. MMP-9"/>
  <result pre="promising therapeutic strategy against cancer. MMP-9 plays critical roles in" exact="cancer" post="pathologies, including tumour angiogenesis, invasion and metastasis and mediates"/>
  <result pre="critical roles in cancer pathologies, including tumour angiogenesis, invasion and" exact="metastasis" post="and mediates the tumour microenvironment by remodeling the extracellular"/>
  <result pre="The HCV and HBV are the common public types of" exact="hepatitis" post="that lead to liver fibrosis, cirrhosis and hepatocellular carcinoma."/>
  <result pre="are the common public types of hepatitis that lead to" exact="liver fibrosis," post="cirrhosis and hepatocellular carcinoma. The prevalence rate of HCV"/>
  <result pre="common public types of hepatitis that lead to liver fibrosis," exact="cirrhosis" post="and hepatocellular carcinoma. The prevalence rate of HCV or"/>
  <result pre="types of hepatitis that lead to liver fibrosis, cirrhosis and" exact="hepatocellular carcinoma." post="The prevalence rate of HCV or HBV is above"/>
  <result pre="worldwide. The therapeutic target for HCV and HBV is blocking" exact="viral" post="replication without any side effects on normal cells, so"/>
  <result pre="M6 (ac: MK063890) could be a new component against both" exact="cancer" post="and viral hepatitis. This studied pigment not only exhibited"/>
  <result pre="MK063890) could be a new component against both cancer and" exact="viral hepatitis." post="This studied pigment not only exhibited caspase-induced apoptotic effects"/>
  <result pre="This studied pigment not only exhibited caspase-induced apoptotic effects in" exact="cancer" post="cells at noncytotoxic doses but also suppressed MMP-9-mediated cancer"/>
  <result pre="in cancer cells at noncytotoxic doses but also suppressed MMP-9-mediated" exact="cancer" post="progression. Furthermore, this pigment was able to inhibit polymerase-dependent"/>
  <result pre="impact of this pigment on the other main mediators of" exact="metastatic" post="cancer and viral hepatitis (particularly HCV) will need further"/>
  <result pre="of this pigment on the other main mediators of metastatic" exact="cancer" post="and viral hepatitis (particularly HCV) will need further investigation"/>
  <result pre="pigment on the other main mediators of metastatic cancer and" exact="viral hepatitis" post="(particularly HCV) will need further investigation using animal models."/>
  <result pre="on the other main mediators of metastatic cancer and viral" exact="hepatitis" post="(particularly HCV) will need further investigation using animal models."/>
  <result pre="molecular identification, a simplified rapid protocol for preparing DNA from" exact="bacterial" post="isolates was used in this study27. This method depends"/>
  <result pre="of the anticancer activity of the pigment against four human" exact="cancer" post="cell lines Determination of the cytotoxicity effect of the"/>
  <result pre="the cytotoxicity effect of the pigment on human normal and" exact="cancer" post="cell lines Normal human lung fibroblast cells (Wi-38) and"/>
  <result pre="of the pigment on human normal and cancer cell lines" exact="Normal" post="human lung fibroblast cells (Wi-38) and a colon cancer"/>
  <result pre="cell lines Normal human lung fibroblast cells (Wi-38) and a" exact="colon cancer" post="line (Caco-2) were maintained as adherent cell cultures in"/>
  <result pre="lines Normal human lung fibroblast cells (Wi-38) and a colon" exact="cancer" post="line (Caco-2) were maintained as adherent cell cultures in"/>
  <result pre="medium (DMEM) containing 10% foetal bovine serum (FBS). A human" exact="liver cancer" post="line (HepG-2), breast cancer line (MCF-7) and cervical cancer"/>
  <result pre="(DMEM) containing 10% foetal bovine serum (FBS). A human liver" exact="cancer" post="line (HepG-2), breast cancer line (MCF-7) and cervical cancer"/>
  <result pre="foetal bovine serum (FBS). A human liver cancer line (HepG-2)," exact="breast cancer" post="line (MCF-7) and cervical cancer line (HeLa) were cultured"/>
  <result pre="bovine serum (FBS). A human liver cancer line (HepG-2), breast" exact="cancer" post="line (MCF-7) and cervical cancer line (HeLa) were cultured"/>
  <result pre="human liver cancer line (HepG-2), breast cancer line (MCF-7) and" exact="cervical cancer" post="line (HeLa) were cultured in Roswell Park Memorial Institute"/>
  <result pre="liver cancer line (HepG-2), breast cancer line (MCF-7) and cervical" exact="cancer" post="line (HeLa) were cultured in Roswell Park Memorial Institute"/>
  <result pre="medium supplemented with 10% FBS (Lonza, USA). Human normal and" exact="cancer" post="cells were seeded in 96-well cell culture plates. After"/>
  <result pre="maximal inhibitory concentration (IC50) for the growth of the tested" exact="cancer" post="cell lines were calculated by GraphPad InStat software. Moreover,"/>
  <result pre="ratio of the EC50 for normal cells to that for" exact="cancer" post="cell lines, was estimated. Furthermore, cellular morphological changes before"/>
  <result pre="changes before and after treatment were examined using a phase-contrast" exact="inverted" post="microscope (Olympus, Japan) with a digital camera and CellSense"/>
  <result pre="using flow cytometry and fluorescence phase contrast microscopy The human" exact="cancer" post="cell lines Caco-2, MCF-7, HepG2 and HeLa were treated"/>
  <result pre="(ethidium bromide and acridine orange dyes). The untreated and treated" exact="cancer" post="cells were stained with these dual nuclear dyes and"/>
  <result pre="fluorescence phase-contrast microscope. Determination of caspase 3/7 activation in pigment-treated" exact="cancer" post="cells Caspase 3/7 activation was measured in untreated and"/>
  <result pre="activity was calculated relative to control MMP-9 activity (in the" exact="absence of" post="pigment and 5-FU), and IC50 values (50% MMP-9 inhibition)"/>
  <result pre="quantification of anti-HCV and anti-HBV activity of the pigment The" exact="viral" post="host cells and human PBMCs (1 × 106 cells) were seeded"/>
  <result pre="of the radiolabelled nucleotide was quantified in the presence and" exact="absence of" post="serial concentrations of the studied pigment or standard anti-HCV"/>
  <result pre="radioactivity using a scintillation counter. The inhibition rate for both" exact="viral" post="polymerase activities was used to assess the IC50 values"/>
  <result pre="and Technological Applications, Alexandria, Egypt, for providing all facilities to" exact="complete" post="this work. The authors gratefully thank Dr. Mohamed I.A."/>
  <result pre="2. BacterioruberinJ. Acta Chem. Scand.1967212578258010.3891/acta.chem.scand.21-2578 12.HuangHMatrix Metalloproteinase-9 (MMP-9) as a" exact="Cancer" post="Biomarker and MMP-9 BiosensorsRecent. Adv. Sens.2018183249 13.Torregrosa-GrespoJGalianaPCEspinosaRMBiocompounds from Haloarchaea"/>
  <result pre="with salt concentrations in a multi-pond salternMicrobiol. Ecol.19851110711510.1007/BF02010483 15.HamidiMAbdin.ZMNazemyieh.HHejazi.AMHejaziSMOptimization of" exact="total" post="carotenoid production by Halorubrum sp. TBZ126 using response surface"/>
  <result pre="Drugs.201816325 18.HouJCuiHLIn Vitro Antioxidant, Antihemolytic, and Anticancer Activity of the" exact="Carotenoids" post="from Halophilic ArchaeaJ. Curr. Microbiol.20187526627110.1007/s00284-017-1374-z 19.ElmoreSApoptosis: a review of"/>
  <result pre="20.SafarpourAEbrahimiMShahzadeh FazeliSAAmoozegarMASupernatant Metabolites from Halophilic Archaea to Reduce Tumorigenesis in" exact="prostate cancer" post="In-vitro and In-vivoIran. J. Pharm. Res.20191824125331089359 21.LiDet al.Biological potential"/>
  <result pre="FazeliSAAmoozegarMASupernatant Metabolites from Halophilic Archaea to Reduce Tumorigenesis in prostate" exact="cancer" post="In-vitro and In-vivoIran. J. Pharm. Res.20191824125331089359 21.LiDet al.Biological potential"/>
  <result pre="mechanism of prodigiosin from Serratia merscens subsp. Lawsoniana in human" exact="choriocarcinoma" post="and prostate cancer cell linesInt. J. Mol. Sci.201819111 22.PalozzaPet"/>
  <result pre="prodigiosin from Serratia merscens subsp. Lawsoniana in human choriocarcinoma and" exact="prostate cancer" post="cell linesInt. J. Mol. Sci.201819111 22.PalozzaPet al.A. Modulation of"/>
  <result pre="from Serratia merscens subsp. Lawsoniana in human choriocarcinoma and prostate" exact="cancer" post="cell linesInt. J. Mol. Sci.201819111 22.PalozzaPet al.A. Modulation of"/>
  <result pre="and its isoform X1 are two novel safe inhibitors for" exact="hepatitis" post="C and B viral entry and replication. Int. J."/>
  <result pre="are two novel safe inhibitors for hepatitis C and B" exact="viral" post="entry and replication. Int. J. Biol. Macromol. 141, 1072-1087"/>
  <result pre="1072-1087 (2019). 24.ZhouWet al.Antiviral and specific modes of action of" exact="bacterial" post="prodigiosin against Bombyx mori nucleopolyhedrovirus In vitroJ. Appl. Microbiol."/>
  <result pre="mori nucleopolyhedrovirus In vitroJ. Appl. Microbiol. Biotechnol.201610039798810.1007/s00253-015-7242-5 25.SunJMet al.Inhibition of" exact="hepatitis" post="C virus replication by Monascus pigment derivatives that interfere"/>
  <result pre="C virus replication by Monascus pigment derivatives that interfere with" exact="viral" post="RNA polymerase activity and the mevalonate biosynthesis pathwayJ. Antimicrob."/>
  <result pre="environmentJ. Astrobiology.20111152953610.1089/ast.2010.0591 27.HolmesDSQuigleyMA rapid boiling method for the preparation of" exact="bacterial" post="plasmidsJ. Anal. Biochem.198111419319710.1016/0003-2697(81)90473-5 28.MooreEArnscheidtAKrÜgerAStrÖmplCMauMSimplified protocols for the preparation of"/>
  <result pre="Biochem.198111419319710.1016/0003-2697(81)90473-5 28.MooreEArnscheidtAKrÜgerAStrÖmplCMauMSimplified protocols for the preparation of genomic DNA from" exact="bacterial" post="culturesJ. Mol. Microb. Ecol. Manual.2004619051919 29.WiddelFTheory and measurement of"/>
  <result pre="bacterial culturesJ. Mol. Microb. Ecol. Manual.2004619051919 29.WiddelFTheory and measurement of" exact="bacterial" post="growthGrundpraktikum Mikrobiologie.20104222234 30.Britton, G. UV/Visible spectroscopy. In: Britton, G.,"/>
  <result pre="factor soluble receptors in patients with various degrees of congestive" exact="heart" post="failureCirculation1995921479148610.1161/01.CIR.92.6.14797664430 37.HirschmanSZGerberMGarfinkelEDifferential activation of hepatitis B DNA polymerase by"/>
  <result pre="with various degrees of congestive heart failureCirculation1995921479148610.1161/01.CIR.92.6.14797664430 37.HirschmanSZGerberMGarfinkelEDifferential activation of" exact="hepatitis" post="B DNA polymerase by detergent and saltJ. Med. Virol.19782617610.1002/jmv.1890020109681913"/>
 </snippets>
</snippetsTree>
